Respiratory News and Research

RSS

Fatigue before cancer treatment impacts fatigue afterwards

Individuals who survive cancer are significantly more likely to develop severe persistent fatigue a year after treatment if they were fatigued before and shortly after treatment, indicate Dutch study findings.

28 Feb 2013

New research reveals special face masks prevent clinical respiratory and bacterial infections

Health care workers who consistently wear special fitted face masks while on duty are much less likely to get clinical respiratory and bacterial infections, according to new research led by University of New South Wales academics.

27 Feb 2013

Children's Oakland CF Center wins 2012 Quality Care Award from Cystic Fibrosis Foundation

Children's Hospital & Research Center Oakland's Cystic Fibrosis Center was recently awarded the Cystic Fibrosis Foundation's 2012 Quality Care Award. This prestigious award recognizes cystic fibrosis (CF) centers committed to improving the quality of patient care and providing better health outcomes for people with the life-threatening genetic disease. Children's Hospital Oakland was among 4 out of 22 centers in the country to receive the CF Foundation's award.

27 Feb 2013

Baxter files FEIBA NF BLA with FDA for prophylactic treatment of hemophilia A or B

Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) supplement to the U.S. Food and Drug Administration (FDA) for the approval of prophylaxis treatment of FEIBA NF [Anti-Inhibitor Coagulant Complex], Nanofiltered and Vapor Heated, in patients with hemophilia A or B and inhibitors.

From Baxter International Inc. 26 Feb 2013

Surgeons told to pull the plug on robotically assisted hysterectomy

US researchers are calling for curbs on the rapidly increasing use of robotically assisted hysterectomy after an extensive study of the technique showed that it fails to improve outcomes over laparoscopy.

26 Feb 2013

COPD benzodiazepine warning

Canadian researchers have found that benzodiazepines are frequently prescribed for patients with chronic obstructive pulmonary disease (COPD), despite their known association with adverse respiratory outcomes.

26 Feb 2013

Direct approach speeds ventilator weaning

Moving straight to unassisted breathing through a tracheostomy collar results in faster weaning than does a gradual reduction in pressure support among patients needing prolonged mechanical ventilation, shows a randomized trial in JAMA.

26 Feb 2013

Radial forearm free flap shows worth in mandibular reconstruction

The osteocutaneous radial forearm free flap should be used for mandibular reconstruction because of the low rate of long-term donor and recipient site complications, particularly with prophylactic plating of the donor radius, say US scientists.

26 Feb 2013

‘Traffic light’ guide for pediatric bacterial infection needs refining

Study results suggest that a “traffic light” system for categorizing the severity of infections in children fails to detect a substantial number of serious bacterial infections, particularly urinary tract infections.

26 Feb 2013

New handheld ultrasound device available from Signostics

Physicians now have access to an even faster and more accurate handheld ultrasound device, with Signostics today unveiling its new “Signos RT” model.

26 Feb 2013

High-level results from AstraZeneca’s naloxegol Phase III trial on opioid-induced constipation

AstraZeneca today announced high-level results from KODIAC-08, an open-label, randomised, 52-week, long-term safety trial of naloxegol versus usual care (UC) in patients with non-cancer related pain and opioid-induced constipation (OIC). UC was defined as the investigator's choice of an existing laxative treatment regimen for OIC.

26 Feb 2013

Researchers to present new results for Merck's allergy immunotherapy tablets at AAAAI meeting

Merck, known as MSD outside the United States and Canada, today announced that researchers will present new data analyses of the safety and efficacy of the company's investigational allergy immunotherapy tablets (AITs) for ragweed pollen (Ambrosia artemisiifolia) and grass pollen (Phleum pratense) at the 2013 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting.

25 Feb 2013

WOEST supports clopidogrel only in PCI patients on anticoagulation

Publication of the WOEST trial results reaffirm the study’s major finding that antiplatelet therapy with clopidogrel alone is preferable to the use of both aspirin and clopidogrel in patients undergoing percutaneous coronary intervention who are receiving oral anticoagulant therapy.

25 Feb 2013